New board appointment at Ariad
This article was originally published in Scrip
Executive Summary
Ariad Pharmaceuticals (US) has appointed Dr Collier Smyth, former senior vice-president of medical strategy, oncology, at Bristol-Myers Squibb, to its board of directors.